<DOC>
	<DOCNO>NCT01819649</DOCNO>
	<brief_summary>This pilot study proceed intend international trial . Hypothesis : Daily intake selenium supplementation form selenium-enriched yeast tablet reduce risk cancer healthy individual . Objective : The objective pilot study assess viability full scale randomise trial .</brief_summary>
	<brief_title>Selenium Prevention Cancer</brief_title>
	<detailed_description />
	<mesh_term>Selenium</mesh_term>
	<criteria>WHO performance status 0 1 No active liver kidney disease ( Serum ALAT ( alanine aminotransferase ) , alkalic phosphatase , bilirubin , creatinin urea within 2 S.D laboratory reference range ) No previous cancer diagnosis No know HIVinfection Participant must understand oral write information Participant must use selenium supplementation 50 mcg/d Participant must give write consent prior inclusion</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>selenium</keyword>
	<keyword>selenium supplementation</keyword>
	<keyword>randomise control trial</keyword>
	<keyword>prevention</keyword>
</DOC>